Chemokines: therapeutic targets for autoimmune and inflammatory renal disease
Chemokines: therapeutic targets for autoimmune and inflammatory renal disease
复制标题
DOI:
10.1007/s00281-003-0124-4
复制
发表时间:
2003-05-01
期刊:
影响因子:
--
通讯作者:
Rovin, BH
中科院分区:
文献类型:
--
作者:
Kelley, VR;Rovin, BH
Chemokines are small (8–12 kDa) chemoattractant cytokines. During inflammation chemokines are crucial in orchestrating leukocyte migration. The rich repertoire of chemokines, and their receptors, permeates nearly every aspect of immunology and has grown to comprise approximately 50 ligands, and 20 G protein-coupled receptors [14, 25, 57]. Initially, chemokines were discovered because they appeared during inflammation. More recently the scope of the role of chemokines has expanded as constitutive expression of chemokines has been shown to regulate homeostatic functions. The daunting list of chemokines is simplified by categorizing them according to the configuration of cysteine residues near the N terminus. There are four chemokine families: CC, CXC, C and CX3C. Thus, in CXC chemokines the first two cysteine residues in the primary amino acid sequence are separated by a single amino acid, whereas in the CC chemokines these cysteine residues are adjacent. The CXC and CC chemokines are by far the largest subfamilies. Chemokines regulate the deployment of leukocytes to tissue sites undergoing pathological change. Leukocytes follow a chemokine gradient. Chemokines are induced in cells during pathological challenge. Extravasation of leukocytes into tissues is a multi-step process involving selectins, integrins and chemokines. Leukocytes loosely adhere to vascular walls by binding to selectins, molecules specialized for adhesion during sheer stress. Chemokines activate integrins, a second group of adhesion molecules. The activated integrins undergo structural/conformational changes that increase their affinity, resulting in firm anchoring of leukocytes to the vessel wall and transmigration of leukocytes across the endothelium. Because leukocytes are responsible for tissue injury, and chemokine release is required for the movement of leukocytes from the blood into tissues, blocking chemokines should prevent inflammation and autoimmune diseases.